US EditionNon-Hodgkin Lymphoma: Know the causes, risk factors, symptoms, and treatment
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Non-Hodgkin Lymphoma: Know the causes, risk factors, symptoms, and treatment
New Delhi: Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in the lymphatic system, a network of vessels, organs, and tissues responsible for defending the body against infections and diseases. NHL is the most common type of lymphoma, accounting for approximately 90% of all lymphoma cases. This cancer occurs when abnormal white blood cells, called lymphocytes, accumulate in the lymph nodes, spleen, or other lymphoid tissues. These…
Diagnosed incident cases of B-cell non-Hodgkin's lymphoma to reach nearly 230,000 in 2033 across 7MM, says GlobalData
The diagnosed incident cases of B-cell non-Hodgkin’s lymphoma (B-cell NHL) in the seven major markets (7MM*) are projected to increase from 200,844 in 2023 to 229,804 in 2033, with an annual growth rate (AGR) of 1.44%, while five-year diagnosed prevalent cases will increase from almost 634,000 to over 714,000 at an AGR of 1.26%, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report “B-Cell Non-Hodgkin’s Lymphoma:…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
